BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30099017)

  • 1. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.
    Yin S; Xia C; Wang Y; Wan D; Rao J; Tang X; Wei J; Wang X; Li M; Zhang Z; Liu J; He Q
    J Control Release; 2018 Oct; 288():148-160. PubMed ID: 30099017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
    Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
    Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
    Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy.
    Liu Y; Mei L; Xu C; Yu Q; Shi K; Zhang L; Wang Y; Zhang Q; Gao H; Zhang Z; He Q
    Theranostics; 2016; 6(2):177-91. PubMed ID: 26877777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced glioma therapy by synergistic inhibition of autophagy and tyrosine kinase activity.
    Wang X; Qiu Y; Yu Q; Li H; Chen X; Li M; Long Y; Liu Y; Lu L; Tang J; Zhang Z; He Q
    Int J Pharm; 2018 Jan; 536(1):1-10. PubMed ID: 28887220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
    Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
    J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis.
    Ren K; He J; Qiu Y; Xu Z; Wang X; Li J; Zang S; Yang Y; Li J; Long Y; Zhang Z; Li M; He Q
    Acta Biomater; 2022 Jun; 145():185-199. PubMed ID: 35447368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor
    Yang Y; Tai X; Shi K; Ruan S; Qiu Y; Zhang Z; Xiang B; He Q
    Theranostics; 2016; 6(12):2141-2160. PubMed ID: 27698946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension.
    Yin Y; Wu X; Yang Z; Zhao J; Wang X; Zhang Q; Yuan M; Xie L; Liu H; He Q
    Pharm Res; 2013 Aug; 30(8):2050-62. PubMed ID: 23756757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer.
    Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q
    J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment.
    Jin X; Li M; Yin L; Zhou J; Zhang Z; Lv H
    Nanomedicine; 2017 Apr; 13(3):1105-1115. PubMed ID: 27845234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
    Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
    Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
    Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
    Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes actively recognizing the glucose transporter GLUT
    Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem Peptide Based on Structural Modification of Poly-Arginine for Enhancing Tumor Targeting Efficiency and Therapeutic Effect.
    Liu Y; Lu Z; Mei L; Yu Q; Tai X; Wang Y; Shi K; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2083-2092. PubMed ID: 28025892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma.
    Liu Y; Mei L; Yu Q; Xu C; Qiu Y; Yang Y; Shi K; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Aug; 7(30):16792-801. PubMed ID: 26173814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Attractive/adhesion force" dual-regulatory nanogels capable of CXCR4 antagonism and autophagy inhibition for the treatment of metastatic breast cancer.
    Dong J; Zhu C; Zhang F; Zhou Z; Sun M
    J Control Release; 2022 Jan; 341():892-903. PubMed ID: 34953982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration.
    Nakamura T; Yamazaki D; Yamauchi J; Harashima H
    J Control Release; 2013 Oct; 171(2):216-24. PubMed ID: 23860186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.